{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["44(11)"],"submitter":["Margalit DN"],"pubmed_abstract":["<h4>Background</h4>Interventions for head/neck cancer (HNC) survivors may not address their cancer-related and general health needs.<h4>Methods</h4>Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guided this systematic review of studies from 2000 to 2021 of interventions targeting cancer survivors treated with curative-intent, using MEDLINE, Embase, Emcare, and PsycINFO. Interventions were categorized into domains of the Quality of Cancer Survivorship Care Framework to characterize the scope and quality of interventions.<h4>Results</h4>We identified 28 studies for inclusion: 13 randomized and 15 non-randomized. Most targeted surveillance/management of physical effects (n = 24) including 13 that also targeted psychosocial effects. Four studies addressed prevention/surveillance for recurrence/new cancers, one addressed health promotion/disease prevention, and one addressed chronic medical conditions. Most studies (n = 27) had medium-high risk of bias.<h4>Conclusions</h4>There are few high-quality studies addressing HNC survivorship. Future rigorously designed studies should address broader areas of care, including chronic disease management and health promotion/disease prevention."],"journal":["Head & neck"],"pagination":["2579-2599"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9796901"],"repository":["biostudies-literature"],"pubmed_title":["Interventions for head and neck cancer survivors: Systematic review."],"pmcid":["PMC9796901"],"pubmed_authors":["Nekhlyudov L","Venchiarutti R","Druce P","McNamara M","Salz T","Milley K","Wong J","Margalit DN","Chima S"],"additional_accession":[]},"is_claimable":false,"name":"Interventions for head and neck cancer survivors: Systematic review.","description":"<h4>Background</h4>Interventions for head/neck cancer (HNC) survivors may not address their cancer-related and general health needs.<h4>Methods</h4>Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guided this systematic review of studies from 2000 to 2021 of interventions targeting cancer survivors treated with curative-intent, using MEDLINE, Embase, Emcare, and PsycINFO. Interventions were categorized into domains of the Quality of Cancer Survivorship Care Framework to characterize the scope and quality of interventions.<h4>Results</h4>We identified 28 studies for inclusion: 13 randomized and 15 non-randomized. Most targeted surveillance/management of physical effects (n = 24) including 13 that also targeted psychosocial effects. Four studies addressed prevention/surveillance for recurrence/new cancers, one addressed health promotion/disease prevention, and one addressed chronic medical conditions. Most studies (n = 27) had medium-high risk of bias.<h4>Conclusions</h4>There are few high-quality studies addressing HNC survivorship. Future rigorously designed studies should address broader areas of care, including chronic disease management and health promotion/disease prevention.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-04T10:59:11.437Z","creation":"2025-02-19T01:57:33.108Z"},"accession":"S-EPMC9796901","cross_references":{"pubmed":["35848095"],"doi":["10.1002/hed.27142"]}}